Prognosis biomarkers of severe sepsis and septic shock by 1h NMR urine metabolomics in the intensive care unit

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Garcia Simon, Monica ^a   Morales, Jose M ^b   Modesto Alapont, Vicente ^c   Gonzalez Marrachelli, Vannina ^d   Vento Rehues, Rosa ^a   Jorda Miñana, Angela ^a   Blanquer Olivas, Jose ^a   Monleon, Daniel ^d  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

^d Instituto Universitario IVI INCLIVA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ARGININE; BIOLOGICAL MARKER; GLUCOSE; GLUTATHIONE; HIPPURIC ACID; METHIONINE; PHENYLALANINE;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; METABOLOMICS; MORTALITY; OUTCOME ASSESSMENT; PREDICTION; PROGNOSIS; PROTON NUCLEAR MAGNETIC RESONANCE; SENSITIVITY AND SPECIFICITY; SEPSIS; SEPTIC SHOCK; SURVIVAL RATE; URINALYSIS; VALIDATION PROCESS; AGED; DISCRIMINANT ANALYSIS; LEAST SQUARE ANALYSIS; METABOLISM; MIDDLE AGED; PROCEDURES; SHOCK, SEPTIC; URINE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; DISCRIMINANT ANALYSIS; FEMALE; HUMANS; INTENSIVE CARE UNITS; LEAST-SQUARES ANALYSIS; MALE; METABOLOMICS; MIDDLE AGED; PROTON MAGNETIC RESONANCE SPECTROSCOPY; SEPSIS; SHOCK, SEPTIC; URINALYSIS; YOUNG ADULT;

EID: 84961332705     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0140993     Document Type: Article

References (31)

1. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006; 34: 344-53.
2. Rivers EP, Ahrens T. Improving outcomes for severe sepsis and septic shock: Tools for early identification of at-risk patients and treatment protocol implementation. Crit Care Clin 2008; 24: S1-47. doi: 10. 1016/j.ccc.2008.04.002
3. Vincent JL, Moreno R, Takala J, Willatts S, De Mendoça A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22: 707-10.
4. Minne L, Abu-Hanna A, de Jonge E. Evaluation of SOFA-based models for predicting mortality in the ICU: A systematic review. Crit Care 2008; 12: R161. doi: 10.1186/cc7160
5. Pierrakos C, Vincent JL. Sepsis biomarkers: A review. Crit Care 2010; 14: R15. doi: 10.1186/cc8872
6. Vincent JL, Teixeira L. Sepsis biomarkers value and limitations. AJRCCM 2014; 190:1081-2.
7. Bodi V, Sanchis J, Morales JM, Marrachelli VG, Nunez J, Forteza MJ, et al. Metabolomic profile of human myocardial ischemia by nuclear magnetic resonance spectroscopy of peripheral blood serum. A translational study based on transient coronary occlusion models. J Am Coll Cardiol 2012; 59: 1629-41. doi: 10.1016/j.jacc.2011.09.083
8. Serkova NJ, Standiford TJ, Stringer KA. The emerging field of quantitative blood metabolomics for biomarker discovery in critical illnesses. Am J Respir Crit Care Med 2011; 184: 647-55. doi: 10.1164/rccm.201103-0474CI
9. Skibsted S, Bhasin MK, Aird WC, Shapiro NI. Bench-To-bedside review: Future novel diagnostics for sepsis-A systems biology approach. Crit Care 2013; 17: 231. doi: 10.1186/cc12693
10. Noto A, Mussap M, Fanos V. Is 1H NMR metabolomics becoming the promising early biomarker for neonatal sepsis and for monitoring the antibiotic toxicity?. J Chemother 2014; 26: 130-2. doi: 10.1179/1973947813Y.0000000149
11. Izquierdo-García JL, Naz S, Nin N, Rojas Y, Erazo M, Martínez-Caro L, et al. A Metabolomic approach to the pathogenesis of ventilator-induced lung injury. Anesthesiology 2014; 120: 694-702. doi: 10. 1097/ALN.0000000000000074
12. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2012; 39: 165-228.
13. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250-6.
14. Holmes E, Foxall PJ, Spraul M, Farrant RD, Nicholson JK, Lindon JC. 750 MHz 1H NMR spectroscopy characterisation of the complex metabolic pattern of urine from patients with inborn errors of metabolism: 2-hydroxyglutaric aciduria and maple syrup urine disease. Anal Chem 1995; 67: 793-811.
15. Eriksson L, Johansson E, Kettaneh-Wold N. Multi-And Megavariate Data Analysis Part I: Basic Principles and Applications. Umea, Sweden, MKS Umetrics AB, 2006.
16. Cabré L, Mancebo J, Solsona JF, Saura P, Gich I, Blanch L, et al. Working group of the SEMICYUC. Multicenter study of the multiple organ dysfunction syndrome in intensive care units: The usefulness of Sequential Organ Failure Assessment scores in decision making. Intensive Care Med 2005; 31: 927-33
17. Luiking YC, Poeze M, Ramsay G, Deutz NE. The role of arginine in infection and sepsis. J Parenter Enteral Nutr 2005; 29: S70-4.
18. Luiking YC, Ten Have GA, Wolfe RR, Deutz NE. Arginine de novo and nitric oxide production in disease states. Am J Physiol Endocrinol Metab 2012; 303: E1177-89. doi: 10.1152/ajpendo.00284.2012
19. Wischmeyer PE. Glutamine: mode of action in critical illness. Crit Care Med 2007; 35: S541-4.
20. Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A, et al. Intensive insulin therapy and mortality among critically ill patients: A meta-Analysis including NICE-SUGAR study data. CMAJ 2009; 180: 821-7. doi: 10.1503/cmaj.090206
21. Lees HJ, Swann JR, Wilson ID, Nicholson JK, Holmes E. Hippurate: The natural history of a mammalian-microbial cometabolite. J Proteome Res 2013; 12: 1527-46. doi: 10.1021/pr300900b
22. Green R, Scott LK, Minagar A, Conrad S. Sepsis associated encephalopathy (SAE): A review. Front Biosci 2004; 9: 1637-41.
23. Zhu L, Baker SS, Gill C, Liu W, Alkhouri R, Baker RD, et al. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH. Hepathology 2013; 57:601-9.
24. Gaspar P, Al-Bayati FA, Andrew PW, Neves AR, Yesilkaya H. Lactate dehydrogenase is the key enzyme for pneumococcal pyruvate metabolism and pneumococcal survival in blood. Infect Immun. 2014; 82:5099-109. doi: 10.1128/IAI.02005-14
25. Richardson AR, Libby SJ, Fang FC. A nitric oxide-inducible lactate dehydrogenase enables Staphylococcus aureus to resist innate immunity. Science 2008; 319: 1672-6. doi: 10.1126/science.1155207
26. Rana NF, Sauvageot N, Laplace JM, Bao Y, Nes I, Rince A, et al. Redox balance via lactate dehydrogenase is important for multiple stress resistance and virulence in Enterococcus faecalis. Infect. Immun 2013; 81:2662-8. doi: 10.1128/IAI.01299-12
27. Antonelli M, Azoulay E, Bonten M, Chastre J, Citerio G, Conti G, et al. Year in review in Intensive Care Medicine, 2008: III. Paediatrics, ethics, outcome research and critical care organization, sedation, pharmacology and miscellanea. Intensive Care Med 2009; 35: 405-16. doi: 10.1007/s00134-009-1433-4
28. Mickiewicz B, Vogel HJ, Wong HR, Winston BW. Metabolomics as a novel approach for early diagnosis of pediatric septic shock and its mortality. Am J Respir Crit Care Med 2013; 187: 967-76. doi: 10.1164/rccm.201209-1726OC
29. Mickiewicz B, Duggan GE, Winston BW, Doig C, Kubes P, Vogel HJ. Alberta Sepsis Network. Metabolic profiling of serum samples by 1H nuclear magnetic resonance spectroscopy as a potential diagnostic approach for septic shock. Crit Care Med 2014; 42: 1140-9. doi: 10.1097/CCM. 0000000000000142
30. Lin ZY, Xu PB, Yan SK, Meng HB, Yang GJ, Dai WX, et al. A metabolomicapproach to early prognostic evaluation of experimental sepsis by 1H NMR and pattern recognition. NMR Biomed 2009; 22: 601-8.
31. Slupsky CM, Rankin KN, Fu H Chang D, Rowe BH, Charles PG, McGeer A, et al. Pneumococcal Pneumonia: Potential for Diagnosis through a Urinary Metabolic Profile. J. Proteome Res 2009, 8: 5550-8. doi: 10.1021/pr9006427